439. Polygenic stratification reveals differential response to V1b antagonism in pre-exposed patients with major depressive disorder: a post-hoc analysis of the phase 2 OLIVE trial
Abstract Background Treatment-resistant depression (TRD), a subtype of major depressive disorder (MDD) defined by suboptimal response to antidepressant treatment, represents a significant unmet medical need. Vasopressin V1b receptor modulation has emerged as a potential mechanism relevant to stress-system dysregulation...